FEMASYS INC (FEMY:NASDAQ)
$1.41 -0.09 (-6%)
Analysed FEMASYS INC (FEMY:NASDAQ) News Sources
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
19-08-2026
yahoo.com
Femasys Secures FDA Approval for Modular PMA Pathway for FemBloc
19-08-2026
advfn.com
FEMY Stock Rallies On Key Regulatory Milestone For Investigational Birth Control Technology – Retail Sees 500% Upside Potential
19-08-2026
stocktwits.com
Femasys Secures FDA Pathway for Non-Surgical Contraceptive
19-08-2026
yahoo.com
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
26-08-2026
yahoo.com
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
15-09-2026
yahoo.com
Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
08-10-2026
yahoo.com
Femasys to Showcase FemaSeed Fertility Treatment at ASRM 2026 as Commercialization Strategy Expands
08-10-2026
advfn.com
Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control
14-10-2026
yahoo.com
Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs
20-10-2026
yahoo.com
What is the current price of FEMASYS INC (FEMY:NASDAQ)?
The current price of FEMASYS INC (FEMY:NASDAQ) is $1.41.
FEMASYS INC (FEMY:NASDAQ) absolute price change since previous trading day?
The absolute price change of FEMASYS INC (FEMY:NASDAQ) since the previous trading day is $-0.09.
FEMASYS INC (FEMY:NASDAQ) percentage price change since previous trading day?
The percentage price change of FEMASYS INC (FEMY:NASDAQ) since the previous trading day is -6%.
What is the most recent average sentiment score for FEMASYS INC (FEMY:NASDAQ)?
The most recent average sentiment score for FEMASYS INC (FEMY:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for FEMASYS INC (FEMY:NASDAQ)?
The most recent sentiment for FEMASYS INC (FEMY:NASDAQ) is .
SEC-8K** Filing Available For FEMASYS INC (FEMY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.